arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Aardvark Therapeutics, Inc.

AARD Health Care Biotechnology: Pharmaceutical Preparations
$5.38
Today
as of Sep 4, 16:45 ET
Last 30 days -16.20% Jul 28 → Sep 04
$5.11 $5.86 $6.61 $7.36 $8.11 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$5.72
High
$5.99
Low
$5.15
Volume
$257,808
Avg Vol
$231,867
Mkt Cap
$129M
P/E (TTM)
Beta
52w High
$17.94
52w Low
$3.35
Div Yield
Shares Out
$22M

Recent Press Releases & News last 60 days · 2 items

Overview

52-week range
$3.35
$18
14% of range
Avg surprise (last 3)
-16.9%
Avg reaction (last 2)
-9.4%
0% positive
Latest IV / EM
367%
EM ±73.4% · $8 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.37$-1.16$-0.95$-0.73$-0.52 Actual $-0.55Actual $-1.37Actual $-1.05Actual $-0.71Est $-0.70Actual $-0.66Est $-0.52Actual $-0.75Actual $-0.99Est $-0.81Actual $-0.66 MarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-22M$-17M$-13M$-9M$-4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.66 financials
Thu May 7, 2026Mar/2026 $-0.99 $-0.81 -22.2% -39.4% -4.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.75 financials
Wed Aug 13, 2025Jun/2025 $-0.66 $-0.52 -26.9% earnings
Wed May 14, 2025Mar/2025 $-0.71 $-0.70 -1.4% -13.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.05 financials
Sun Jun 30, 2024Jun 2024 $-1.37 financials
Sun Mar 31, 2024Mar 2024 $-0.55 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-15M$-22M$-18M$-16M$-10M$-5M
Net income$-14M$-22M$-16M$-14M$-9M$-4M
EPS (diluted)$-0.66$-0.99$-0.75$-0.66$-0.71$-1.05

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$74M$62M$47M$39M$26M$27M$62M
Inventory
Total current assets$81M$94M$112M$129M$145M$155M$74M
Total assets$81M$99M$117M$133M$147M$157M$78M
Long-term debt
Total liabilities$7M$12M$11M$11M$11M$6M$5M
Total equity$75M$87M$107M$122M$137M$151M$-55M$-46M

Implied volatility — last 90 days

29%591%1152%1714%2275% Jun 07 — IV 29% · EM ±4.1%Jun 08 — IV 1055% · EM ±139.3%Jun 09 — IV 1115% · EM ±139.7%Jun 10 — IV 36% · EM ±4.3%Jun 16 — IV 2276% · EM ±134.4%Jun 22 — IV 593% · EM ±123.8%Jun 23 — IV 612% · EM ±125.3%Jun 24 — IV 526% · EM ±105.3%Jun 25 — IV 526% · EM ±103.0%Jul 06 — IV 356% · EM ±49.2%Jul 09 — IV 576% · EM ±68.0%Jul 10 — IV 384% · EM ±42.5%Jul 13 — IV 1023% · EM ±85.4%Jul 14 — IV 640% · EM ±46.3%Jul 16 — IV 57% · EM ±2.4%Jul 20 — IV 144% · EM ±34.1%Jul 22 — IV 290% · EM ±66.4%Jul 23 — IV 351% · EM ±79.0%Jul 24 — IV 227% · EM ±50.2%Jul 27 — IV 122% · EM ±25.4%Jul 28 — IV 274% · EM ±56.1%Jul 29 — IV 436% · EM ±87.2%Jul 30 — IV 325% · EM ±63.7%Jul 31 — IV 439% · EM ±84.1%Aug 03 — IV 353% · EM ±62.5%Aug 04 — IV 478% · EM ±82.3%Aug 05 — IV 404% · EM ±67.5%Aug 06 — IV 447% · EM ±72.3%Aug 07 — IV 435% · EM ±68.0%Aug 10 — IV 468% · EM ±64.8%Aug 11 — IV 500% · EM ±66.1%Aug 12 — IV 109% · EM ±13.7%Aug 13 — IV 374% · EM ±44.2%Aug 14 — IV 152% · EM ±16.8%Aug 17 — IV 80% · EM ±6.7%Aug 19 — IV 38% · EM ±2.2%Aug 20 — IV 52% · EM ±2.2%Aug 24 — IV 348% · EM ±72.7%Aug 25 — IV 222% · EM ±45.5%Aug 26 — IV 367% · EM ±73.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.